ReviewThe oncologist2022

Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib.

Seth A Wander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.